Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:ATCCode |
gptkb:J01CF06
|
| gptkbp:CASNumber |
gptkb:147-84-2
|
| gptkbp:chemicalFormula |
C21H21N2NaO5S
|
| gptkbp:contraindication |
hypersensitivity to penicillins
|
| gptkbp:discoveredIn |
1960s
|
| gptkbp:eliminationHalfLife |
0.5 to 1 hour
|
| gptkbp:excretion |
renal
biliary |
| https://www.w3.org/2000/01/rdf-schema#label |
nafcillin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:metabolism |
hepatic
|
| gptkbp:molecularWeight |
454.46 g/mol
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:proteinBinding |
90% or more
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
phlebitis
allergic reaction neutropenia liver dysfunction |
| gptkbp:synonym |
gptkb:Nafcil
|
| gptkbp:usedFor |
treatment of infections caused by Staphylococcus aureus
|
| gptkbp:bfsParent |
gptkb:MSSA
|
| gptkbp:bfsLayer |
6
|